255 related articles for article (PubMed ID: 21214147)
1. Orbital fibrosis and intraocular recurrence of retinoblastoma following periocular carboplatin.
Kim JW; Yau JW; Moshfeghi D; Fishman M
J Pediatr Ophthalmol Strabismus; 2010 May; 47 Online():e1-4. PubMed ID: 21214147
[TBL] [Abstract][Full Text] [Related]
2. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
5. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
Demirci H; Eagle RC; Shields CL; Shields JA
Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
[TBL] [Abstract][Full Text] [Related]
7. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
9. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
Mulvihill A; Budning A; Jay V; Vandenhoven C; Heon E; Gallie BL; Chan HS
Arch Ophthalmol; 2003 Aug; 121(8):1120-4. PubMed ID: 12912689
[TBL] [Abstract][Full Text] [Related]
10. What is the best treatment for retinoblastoma?
Harbour JW
Am J Ophthalmol; 2004 Sep; 138(3):471-3. PubMed ID: 15364232
[No Abstract] [Full Text] [Related]
11. Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.
Dai S; Dimaras H; Héon E; Budning A; Doyle J; Halliday W; Drake J; Gallie BL; Chan HS
Ophthalmic Genet; 2008 Sep; 29(3):120-5. PubMed ID: 18766991
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
13. Ophthalmic vasculature alterations following systemic chemotherapy and periocular Carboplatin treatment of advanced retinoblastoma.
Piña Y; Boutrid H; Murray TG; Wolfe SQ; Schefler AC; Houston SK; Moftakhar R; Fernandes CE; Reichbach J; Aziz HA; Markoe AM; Aziz-Sultan MA
J Pediatr Ophthalmol Strabismus; 2010 Sep; 47 Online():e1-5. PubMed ID: 20886809
[TBL] [Abstract][Full Text] [Related]
14. Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Am J Ophthalmol; 2004 Sep; 138(3):329-37. PubMed ID: 15364213
[TBL] [Abstract][Full Text] [Related]
15. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Ness S; Meadows AT; Shields JA
Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
[TBL] [Abstract][Full Text] [Related]
16. Management of advanced retinoblastoma with intravenous chemotherapy then intra-arterial chemotherapy as alternative to enucleation.
Shields CL; Kaliki S; Al-Dahmash S; Rojanaporn D; Leahey A; Griffin G; Jabbour P; Shields JA
Retina; 2013; 33(10):2103-9. PubMed ID: 23873161
[TBL] [Abstract][Full Text] [Related]
17. Retinocytoma shows lack of response to chemoreduction.
Chung J; Turaka K; Shields CL
J Pediatr Ophthalmol Strabismus; 2010 Dec; 47 Online():e1-3. PubMed ID: 21175116
[TBL] [Abstract][Full Text] [Related]
18. Sudden dispersion of retinoblastoma shortly after initial chemotherapy treatment.
Parness-Yossifon R; Bryar PJ; Weinstein JL; Srikumaran D; Mets MB
Am J Ophthalmol; 2009 May; 147(5):903-6. PubMed ID: 19232557
[TBL] [Abstract][Full Text] [Related]
19. Eye salvage in diffuse anterior retinoblastoma using systemic chemotherapy with periocular and intravitreal topotecan.
Rao R; Honavar SG; Mulay K; Reddy VAP
J AAPOS; 2018 Jun; 22(3):235-237.e2. PubMed ID: 29698780
[TBL] [Abstract][Full Text] [Related]
20. MRI findings at baseline and after neoadjuvant chemotherapy in orbital retinoblastoma (IRSS stage III).
Radhakrishnan V; Sharma S; Vishnubhatla S; Bakhshi S
Br J Ophthalmol; 2013 Jan; 97(1):52-8. PubMed ID: 23117972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
